Innovative AI Solutions Aignostics specializes in cutting-edge AI technologies for pathology and precision medicine, making it a prime partner for biopharma companies seeking advanced data-driven insights to accelerate drug development and clinical trials.

Strategic Collaborations With recent partnerships like Mayo Clinic and collaborations with biopharma firms, Aignostics demonstrates a strong ability to integrate its pathology models into real-world clinical and research settings, opening opportunities for scaled enterprise solutions.

Robust Funding & Growth Having secured over 34 million dollars in funding and achieved a Series B raise of 33.9 million euros, Aignostics is positioned for aggressive expansion and product development, presenting opportunities for investment and enterprise expansion services.

Scalable Research Platform The launch of a state-of-the-art pathology foundation model and its application in large-scale histopathology imaging suggest a valuable opportunity to offer comprehensive AI-powered diagnostic tools to healthcare and research organizations.

Global Presence & Expertise With operations in Berlin and New York and a strong academic background from Charité Berlin, Aignostics can facilitate international collaborations and provide tailored solutions for global biotech and pharma clients seeking innovative AI-driven diagnostic capabilities.